Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$549K Buy
4,159
+200
+5% +$24.7K 0.79% 30
2023
Q4
$432K Sell
3,959
-200
-5% -$20.8K 0.65% 32
2023
Q3
$428K Hold
4,159
0.69% 33
2023
Q2
$480K Hold
4,159
0.72% 33
2023
Q1
$442K Hold
4,159
0.7% 35
2022
Q4
$461K Hold
4,159
0.73% 34
2022
Q3
$359K Hold
4,159
0.64% 41
2022
Q2
$379K Hold
4,159
0.65% 42
2022
Q1
$341K Hold
4,159
0.49% 49
2021
Q4
$319K Buy
+4,159
New +$331K 0.44% 56

Other funds holding MRK

Norwood Financial's MRK Position: Q1 2024 in Review

Norwood Financial increased its Merck (MRK) stake by 5.1% in Q1 2024, buying an estimated $24.7K and bringing the position to 4,159 shares worth $549K. The position accounts for 0.79% of the portfolio, ranked #30.

Norwood Financial first reported a position in MRK in Q4 2021 and has held it in 10 quarters since. 3,536 funds tracked by Wall St. Rank hold MRK as of Q1 2024.

  • Norwood Financial held 4,159 shares of Merck worth $549K as of Q1 2024.
  • Norwood Financial bought 200 Merck shares in Q1 2024, an estimated $24.7K.
  • Merck made up 0.79% of Norwood Financial's portfolio in Q1 2024, its #30 holding.
  • Norwood Financial first reported a position in Merck in Q4 2021 and has held it in 10 quarters since.
  • 3,536 funds tracked by Wall St. Rank held Merck as of Q1 2024.

Based on Norwood Financial's 13F filing for Q1 2024, filed 16 Apr 2024.